Jaguar Health Provides Update Regarding Special Stock Dividend
Jaguar Health announced that Nasdaq set the ex-dividend date of October 16, 2026 for its previously announced Special Stock Dividend of Series R Convertible Preferred Stock. Shares will trade with due bills from the October 13 record date until the ex-dividend date, meaning sellers during that period give up their right to the dividend.
Key figures
- Drug Name
- crofelemer
- Record date
- October 13, 2026
- Ex dividend date
- October 16, 2026
- Nda filing target
- mid-2027 for crofelemer in MVID
- Dividend instrument
- Series R Convertible Preferred Stock
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.